Angiogenic Properties of Concentrated Growth Factors (CGFs): The Role of Soluble Factors and Cellular Components

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2021 May 5

PMID 33946931

Citations 13

Authors

Nadia Calabriso

Eleonora Stanca

Alessio Rochira

Fabrizio Damiano

Laura Giannotti

Benedetta Di Chiara Stanca

Marika Massaro

Egeria Scoditti

Christian Demitri

Paola Nitti

Andrea Palermo

Luisa Siculella

Maria Annunziata Carluccio

Affiliations

Soon will be listed here.

Abstract

Blood-derived concentrated growth factors (CGFs) represent a novel autologous biomaterial with promising applications in regenerative medicine. Angiogenesis is a key factor in tissue regeneration, but the role played by CGFs in vessel formation is not clear. The purpose of this study was to characterize the angiogenic properties of CGFs by evaluating the effects of its soluble factors and cellular components on the neovascularization in an in vitro model of angiogenesis. CGF clots were cultured for 14 days in cell culture medium; after that, CGF-conditioned medium (CGF-CM) was collected, and soluble factors and cellular components were separated and characterized. CGF-soluble factors, such as growth factors (VEGF and TGF-β1) and matrix metalloproteinases (MMP-2 and -9), were assessed by ELISA. Angiogenic properties of CGF-soluble factors were analyzed by stimulating human cultured endothelial cells with increasing concentrations (1%, 5%, 10%, or 20%) of CGF-CM, and their effect on cell migration and tubule-like formation was assessed by wound healing and Matrigel assay, respectively. The expression of endothelial angiogenic mediators was determined using qRT-PCR and ELISA assays. CGF-derived cells were characterized by immunostaining, qRT-PCR and Matrigel assay. We found that CGF-CM, consisting of essential pro-angiogenic factors, such as VEGF, TGF-β1, MMP-9, and MMP-2, promoted endothelial cell migration; tubule structure formation; and endothelial expression of multiple angiogenic mediators, including growth factors, chemokines, and metalloproteinases. Moreover, we discovered that CGF-derived cells exhibited features such as endothelial progenitor cells, since they expressed the CD34 stem cell marker and endothelial markers and participated in the neo-angiogenic process. In conclusion, our results suggest that CGFs are able to promote endothelial angiogenesis through their soluble and cellular components and that CGFs can be used as a biomaterial for therapeutic vasculogenesis in the field of tissue regeneration.

Citing Articles

Regenerative potential of concentrated growth factor compared to platelet-rich fibrin in treatment of necrotic mature teeth: a randomized clinical trial.

Salah T, Hussein W, Abdelkafy H BDJ Open. 2025; 11(1):10.

PMID: 39900647 PMC: 11790909. DOI: 10.1038/s41405-024-00288-3.

Autologous Growth Factor-Rich Concentrate (GFC) Injection in Non-union of Fractures: A Quasi-experimental Study.

Jain K, Jeyaraman M, Jeyaraman N, Gupta A Indian J Orthop. 2024; 58(12):1833-1843.

PMID: 39664350 PMC: 11628475. DOI: 10.1007/s43465-024-01278-1.

Assessment of the efficacy of autologous blood preparations in maxillary sinus floor elevation surgery: a systematic review and meta-analysis.

Qiu P, Zhang X, Cao R, Xu H, Jiang Z, Lei J BMC Oral Health. 2024; 24(1):1171.

PMID: 39363273 PMC: 11451106. DOI: 10.1186/s12903-024-04938-8.

Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies.

Atrooz O, Reihani N, Mozafari M, Salawi A, Taghavi E ADMET DMPK. 2024; 12(3):431-462.

PMID: 39091900 PMC: 11289513. DOI: 10.5599/admet.2376.

Application of Graphene Oxide in Oral Surgery: A Systematic Review.

Inchingolo F, Inchingolo A, Latini G, Palmieri G, Di Pede C, Trilli I Materials (Basel). 2023; 16(18).

PMID: 37763569 PMC: 10532659. DOI: 10.3390/ma16186293.

References

Calabriso N, Massaro M, Scoditti E, DAmore S, Gnoni A, Pellegrino M . Extra virgin olive oil rich in polyphenols modulates VEGF-induced angiogenic responses by preventing NADPH oxidase activity and expression. J Nutr Biochem. 2016; 28:19-29. DOI: 10.1016/j.jnutbio.2015.09.026. View

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

Carmeliet P . Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6(4):389-95. DOI: 10.1038/74651. View

Honda H, Tamai N, Naka N, Yoshikawa H, Myoui A . Bone tissue engineering with bone marrow-derived stromal cells integrated with concentrated growth factor in Rattus norvegicus calvaria defect model. J Artif Organs. 2013; 16(3):305-15. DOI: 10.1007/s10047-013-0711-7. View

Hong S, Li L, Cai W, Jiang B . The potential application of concentrated growth factor in regenerative endodontics. Int Endod J. 2018; 52(5):646-655. DOI: 10.1111/iej.13045. View

Lovett M, Lee K, Edwards A, Kaplan D . Vascularization strategies for tissue engineering. Tissue Eng Part B Rev. 2009; 15(3):353-70. PMC: 2817665. DOI: 10.1089/ten.TEB.2009.0085. View

Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M . Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999; 85(3):221-8. DOI: 10.1161/01.res.85.3.221. View

Kim T, Kim S, K Sandor G, Kim Y . Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014; 59(5):550-8. DOI: 10.1016/j.archoralbio.2014.02.004. View

Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S . Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009; 37(11):2259-72. DOI: 10.1177/0363546509349921. View

10.

Liekens S, De Clercq E, Neyts J . Angiogenesis: regulators and clinical applications. Biochem Pharmacol. 2001; 61(3):253-70. DOI: 10.1016/s0006-2952(00)00529-3. View

11.

Isobe K, Watanebe T, Kawabata H, Kitamura Y, Okudera T, Okudera H . Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF). Int J Implant Dent. 2017; 3(1):17. PMC: 5413460. DOI: 10.1186/s40729-017-0081-7. View

12.

Conway E, Collen D, Carmeliet P . Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3):507-21. DOI: 10.1016/s0008-6363(00)00281-9. View

13.

Wang F, Sun Y, He D, Wang L . Effect of Concentrated Growth Factors on the Repair of the Goat Temporomandibular Joint. J Oral Maxillofac Surg. 2016; 75(3):498-507. DOI: 10.1016/j.joms.2016.09.006. View

14.

Kurita J, Miyamoto M, Ishii Y, Aoyama J, Takagi G, Naito Z . Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Ann Thorac Surg. 2011; 92(3):837-44. DOI: 10.1016/j.athoracsur.2011.04.084. View

15.

Gassling V, Acil Y, Springer I, Hubert N, Wiltfang J . Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108(1):48-55. DOI: 10.1016/j.tripleo.2009.02.007. View

16.

Wang L, Wan M, Li Z, Zhong N, Liang D, Ge L . A comparative study of the effects of concentrated growth factors in two different forms on osteogenesis in vitro. Mol Med Rep. 2019; 20(2):1039-1048. PMC: 6625392. DOI: 10.3892/mmr.2019.10313. View

17.

Ziegler M, Hatch M, Wu N, Muawad S, Hughes C . mTORC2 mediates CXCL12-induced angiogenesis. Angiogenesis. 2016; 19(3):359-71. PMC: 4959910. DOI: 10.1007/s10456-016-9509-6. View

18.

Sanchez-Gonzalez D, Mendez-Bolaina E, Trejo-Bahena N . Platelet-rich plasma peptides: key for regeneration. Int J Pept. 2012; 2012:532519. PMC: 3303558. DOI: 10.1155/2012/532519. View

19.

Park H, Yang J, Chung K . Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells. Korean J Hematol. 2012; 46(4):265-73. PMC: 3259519. DOI: 10.5045/kjh.2011.46.4.265. View

20.

Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D . Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2019; 91(4):462-472. DOI: 10.1002/JPER.19-0290. View